전 세계적으로 운영되는 콜게이트-팜올리브 컴퍼니(Colgate-Palmolive Company)와 그 계열사는 다양한 소비재의 생산 및 유통에 종사하고 있습니다. 회사의 사업은 크게 두 개의 주요 부문으로 ...
콜게이트-팜올리브 주식은 구강 케어, 퍼스널 케어, 홈 케어, 반려동물 영양을 아우르는 글로벌 소비자 브랜드 사업에 대한 꾸준한 노출을 제공합니다. 이 회사는 강력한 브랜드 자산, 규모의 이점, 선진 및 신흥 시장 전반에 걸친 다각화된 매출원에서 혜택을 누리고 있습니다. 지속적인 현금 창출과 배당 이력은 포트폴리오에서 안정성을 원하는 방어적 투자자들에게 매력적입니다.
Procyon Advisors LLC는 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)의 지분을 27.9% 늘려 추가로 11,277주를 매수했습니다. 이에 따라 총 보유 주식 수는 51,721주로 늘었으며, 가치는 4,408,000달러입니다. 다른 여러 기관 투자자들도 보유 지분을 조정했으며, 기관 투자자와 헤지펀드가 합쳐서 회사 주식의 80.41%를 보유하고 있습니다.
Paradiem LLC는 2026년 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)에 1,321만 달러 규모의 신규 투자를 단행했으며, 154,940주를 매수했습니다. 이 지분은 현재 Paradiem의 총 보유 지분의 2.9%를 차지하며, 회사의 14번째로 큰 포지션입니다. 콜게이트-팜올리브는 최근 강한 분기 실적을 발표해, 주당 0.97달러의 이익과 53.2억 달러의 매출을 기록하며 애널리스트 예상치를 상회했는데, 이는 전년 대비 8.4% 증가한 수치입니다.
Candriam S.C.A.는 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)의 지분을 24.9% 늘려 현재 128,079주를 보유하고 있으며, 평가가치는 10,916,000달러입니다. 다른 기관 투자자들도 회사의 보유 지분을 조정했습니다. 콜게이트-팜올리브는 최근 강한 분기 실적을 발표해 애널리스트 예상치를 상회했으며, 8월 14일에 지급 예정인 주당 0.53달러의 분기 배당금도 발표했습니다.
AMF Tjanstepension AB는 1분기에 Colgate-Palmolive Company(뉴욕증권거래소: CL) 지분을 45.7% 크게 줄여 717,332주를 매도하고 850,709주를 보유했으며, 이는 7,250만 달러 규모다. 그럼에도 다른 기관 투자자들은 포지션을 조정했으며, 헤지펀드와 기관 투자자가 보유한 주식 비중은 80.41%에 달한다. Colgate-Palmolive(뉴욕증권거래소: CL)는 최근 강한 1분기 실적을 발표해 애널리스트 기대치를 상회했으며, 주당 0.53달러의 분기 배당금을 발표했다.
콜게이트-팜올리브 주식은 구강 케어, 퍼스널 케어, 홈 케어, 반려동물 영양을 아우르는 글로벌 소비자 브랜드 사업에 대한 꾸준한 노출을 제공합니다. 이 회사는 강력한 브랜드 자산, 규모의 이점, 선진 및 신흥 시장 전반에 걸친 다각화된 매출원에서 혜택을 누리고 있습니다. 지속적인 현금 창출과 배당 이력은 포트폴리오에서 안정성을 원하는 방어적 투자자들에게 매력적입니다.
Procyon Advisors LLC는 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)의 지분을 27.9% 늘려 추가로 11,277주를 매수했습니다. 이에 따라 총 보유 주식 수는 51,721주로 늘었으며, 가치는 4,408,000달러입니다. 다른 여러 기관 투자자들도 보유 지분을 조정했으며, 기관 투자자와 헤지펀드가 합쳐서 회사 주식의 80.41%를 보유하고 있습니다.
Paradiem LLC는 2026년 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)에 1,321만 달러 규모의 신규 투자를 단행했으며, 154,940주를 매수했습니다. 이 지분은 현재 Paradiem의 총 보유 지분의 2.9%를 차지하며, 회사의 14번째로 큰 포지션입니다. 콜게이트-팜올리브는 최근 강한 분기 실적을 발표해, 주당 0.97달러의 이익과 53.2억 달러의 매출을 기록하며 애널리스트 예상치를 상회했는데, 이는 전년 대비 8.4% 증가한 수치입니다.
Candriam S.C.A.는 1분기 동안 콜게이트-팜올리브 컴퍼니(뉴욕: CL)의 지분을 24.9% 늘려 현재 128,079주를 보유하고 있으며, 평가가치는 10,916,000달러입니다. 다른 기관 투자자들도 회사의 보유 지분을 조정했습니다. 콜게이트-팜올리브는 최근 강한 분기 실적을 발표해 애널리스트 예상치를 상회했으며, 8월 14일에 지급 예정인 주당 0.53달러의 분기 배당금도 발표했습니다.
AMF Tjanstepension AB는 1분기에 Colgate-Palmolive Company(뉴욕증권거래소: CL) 지분을 45.7% 크게 줄여 717,332주를 매도하고 850,709주를 보유했으며, 이는 7,250만 달러 규모다. 그럼에도 다른 기관 투자자들은 포지션을 조정했으며, 헤지펀드와 기관 투자자가 보유한 주식 비중은 80.41%에 달한다. Colgate-Palmolive(뉴욕증권거래소: CL)는 최근 강한 1분기 실적을 발표해 애널리스트 기대치를 상회했으며, 주당 0.53달러의 분기 배당금을 발표했다.
Fifth Third Bancorp는 1분기에 Colgate-Palmolive Company(뉴욕증권거래소: CL) 지분을 472.0% 크게 늘려 현재 474,692주를 보유하고 있으며, 가치는 약 4,046만 달러다. 다른 기관 투자자들도 포지션을 조정했으며, 애널리스트들은 전반적으로 CL에 대해 "Moderate Buy(중립적 매수)" 등급을 유지하고, 합의 목표주가를 96.29달러로 제시하고 있다. 회사는 최근 강한 분기 실적을 발표해 전망치를 상회했으며, 주당 0.53달러의 분기 배당금도 발표했다.
Colgate-Palmolive(CL)는 주식을 고려할 만한 설득력 있는 두 가지 이유를 제시한다. 바로 60.4%의 엘리트 수준 총마진과 최근 2년간 평균 17.8%의 훌륭한 잉여현금흐름(FCF) 마진이다. 이러한 재무적 강점은 강력한 가격 결정력과 견고한 재투자 잠재력을 시사한다. 다만, 연간 3.6%의 느린 유기적 성장에 대해 경고의 목소리가 제기되며, 핵심 사업에서 수요가 둔화될 가능성을 암시한다.
이 글은 프록터 & 갬블(P&G)과 펩시코(PEP)의 최근 실적 보고와 전략적 방향을 비교하며, 패시브 인컴 관점에서 어느 쪽이 더 나은 투자일 수 있는지 논의한다. P&G는 뷰티 부문이 주도한 전반적인 성장세를 보였고 비용 절감 조치도 시행하고 있다. 반면 펩시코는 국제 시장에서 강한 성장세를 보였지만, 국내 스낵 부문에서는 하락이 나타났다. 저자는 더 깔끔한 운영 스토리와 안정적인 성장이라는 점에서 P&G 쪽에, 그리고 현재 가치평가와 배당수익률을 바탕으로 한 반등 트레이드 가능성에 대해 펩시코를 선호한다.
Colgate-Palmolive stock represents a steady investment in a global consumer staples company, underpinned by strong oral care, personal care, home care, and pet nutrition brands. The company's focus on essential products, resilient cash flows, and diversified portfolio across developed and emerging markets contributes to its stable profile and dividend capacity. This positioning makes Colgate-Palmolive an attractive holding for investors seeking lower volatility and predictable returns in a consumer staples portfolio.
Clorox (NYSE:CLX) shares rose 3.8% in New York, maintaining a 5% dividend yield, but the dividend's sustainability is being questioned due to an 89% payout ratio. The stock closed at $96.56, offering a 5.14% yield, which is higher than the 10-year U.S. Treasury, but its income cushion appears thin with earnings barely covering the dividend. The company faces challenges from operational resets, higher costs, and potential shifts in interest rates, which could further squeeze its dividend margin despite a higher yield compared to peers.
This article provides financial data for Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs (BCBA:CLD) on TradingView. It specifically highlights the Enterprise Value to EBITDA forward metric. The information is presented within the context of market data, news, and technical analysis tools available on the platform.
Conning Inc. has reduced its stake in Colgate-Palmolive Company by 9.9% in the first quarter, selling 42,092 shares, though its remaining holdings are still valued at approximately $32.8 million. Colgate-Palmolive (NYSE:CL) surpassed quarterly expectations for both EPS and revenue, reporting $0.97 EPS on $5.32 billion in revenue. The company also reaffirmed its quarterly dividend of $0.53 per share, resulting in an annualized yield of 2.3%, and currently holds a "Moderate Buy" consensus rating from analysts with an average target price of $96.29.
First Horizon Corp significantly increased its stake in Colgate-Palmolive Company, purchasing an additional 31,583 shares and bringing its total holdings to 45,200 shares valued at $3.85 million. This coincides with Colgate-Palmolive reporting better-than-expected quarterly earnings and revenue, alongside declaring a $0.53 per share quarterly dividend. Analysts currently rate the stock as a "Moderate Buy" with an average price target of $96.29.
Colgate-Palmolive (ISIN: US1941621039) is a global consumer staples company known for its oral care, personal care, home care, and pet nutrition products. The company benefits from resilient demand for its everyday hygiene and household items across economic cycles, making its stock a potentially defensive holding. Colgate-Palmolive maintains a strong market presence through diversified products, continuous brand support, and efficiency measures, ensuring stable financial performance and competitive positioning.
This article highlights key healthcare developments, including Colgate-Palmolive's extended commitment to oral health education, a collaboration between the Fleming Initiative and AWS using generative AI to combat antimicrobial resistance, and Microsoft AI's deployment in social care by Lancashire County Council to save administrative hours. It also touches on a UK-US pharmaceutical deal and Novo Nordisk's strategy for weight management.
This article examines three consumer staples companies—Dollar Tree (DLTR), Sprouts Farmers Market (SFM), and Colgate-Palmolive (CL)—and their exposure to tariff-driven inflation. It discusses how each company's business model, financial health, and pricing power position them to either benefit or be challenged by rising costs and household budget pressures. The analysis highlights their recent financial performance, analyst outlooks, and potential risks and rewards for long-term investors.
This article provides financial information for Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs (BCBA:CLD) on the Buenos Aires Stock Exchange, specifically focusing on its enterprise value to EBIT forward ratio. It notes that the market is currently closed with no trades. The article is sourced from TradingView and includes standard disclaimers about market and reference data providers.
Kimberly-Clark stock remains stable due to consistent consumer demand for its tissue and personal care products, which are considered consumer staples. The company's long-term earnings profile is supported by its strong brands, predictable cash flow, and global market positioning. Despite exposure to commodity costs, Kimberly-Clark manages profitability through cost efficiencies and pricing strategies, making it an attractive dividend stock for income-oriented investors seeking stability.
Colgate-Palmolive stock (ISIN US1941621039) reflects the company's strong position as a global consumer staples player with resilient brands in oral care, personal care, home care, and pet nutrition. The company's business model relies on high-volume, relatively low-priced daily necessities, ensuring recurring demand and less volatility compared to cyclical sectors. Strategic focus on brand strength, innovation, and efficient global operations, particularly in emerging markets, supports long-term growth and stable financial performance for investors.
Sumitomo Mitsui Trust Group Inc. reduced its stake in Colgate-Palmolive Company by 3.4% during the first quarter, selling 63,595 shares. Despite the sell-off, Colgate-Palmolive reported strong quarterly earnings, beating analyst estimates with $0.97 EPS and $5.32 billion in revenue, and announced a quarterly dividend of $0.53 per share, representing an annualized yield of 2.3%. The company holds a "Moderate Buy" consensus rating from analysts with an average price target of $96.29.
Colgate-Palmolive stock demonstrates a resilient consumer staples profile, driven by consistent demand for its oral care, personal care, and home products across global markets. The company's profitability is influenced by its ability to manage costs, apply pricing strategies, and innovate, while its presence in emerging markets offers growth opportunities alongside currency exposure risks. Inclusion in major US equity benchmarks like the S&P 500 ensures steady investor interest, complementing its strategy of diversified product portfolios and a strong focus on sustainability and digital channels.
This article announces the discontinued operations of Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs, traded on the Buenos Aires Stock Exchange under the ticker CL.CI. The content is concise, indicating that there are no current trades or financial data available for this specific entry.
Colgate-Palmolive reported an 8.4% increase in net sales for Q1 2026, reaching Rs 5.324 billion, with organic sales growing by 2.9%. The company maintained its leadership in the global oral care market and saw strong growth across Latin America, Europe, Middle East, Africa, and Asia Pacific. Colgate-Palmolive also announced an expansion of its Strategic Growth and Productivity Program and reaffirmed its full-year sales and earnings guidance, despite revising its gross profit margin outlook.
Piper Sandler analyst Michael Lavery maintained an Overweight rating on Colgate-Palmolive (CL) and raised the price target from $92.00 to $96.00. GuruFocus indicates that CL is 2.0% undervalued with a GF Value™ of $93.94, despite a higher-than-median P/E ratio, and has a strong GF Score™ of 82/100, though insider activity shows recent selling.
This article provides financial information for Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs (BCBA:CLD) on the Buenos Aires Stock Exchange. It specifically highlights the "Price to sales forward" metric. The page appears to be a financial data portal displaying key metrics for the company.
Colgate-Palmolive is highlighted as a global consumer staples company with a strong focus on oral, personal, and home care products, particularly its dominant position in oral care across diverse markets. The company's business model relies on brand strength, innovation, and extensive distribution networks to drive earnings through volume growth, strategic pricing, and product mix improvements. It offers investors a defensive profile due to recurring demand and a globally diversified brand portfolio, appealing to those seeking exposure to household and personal care products.
Wells Fargo has increased its price target for Colgate-Palmolive (CL) to $95 from the previous target of $92. This adjustment reflects an updated outlook on the company's stock by the financial institution. Colgate-Palmolive's stock was trading at $95.03, showing a 1.76% increase.
This article details Dentagard Zahnpasta, a Colgate-Palmolive product offering herbal fluoride cavity protection with a mint-herb taste, primarily marketed in Germany. It discusses the product's positioning within Colgate's oral-care portfolio, its ingredients, and its role as a stable, traditional option for families. The article also touches on Dentagard's strategic importance for Colgate-Palmolive in the European market and its contribution to the company's stock performance.
Colgate-Palmolive is refining its long-term strategy, emphasizing brand strength, innovation, and cost efficiency across its diverse portfolio of oral care, personal care, home care, and pet nutrition products. The company aims to maintain its position as a global consumer staples leader through consistent investment in brands, targeted innovation, disciplined cost management, and leveraging its worldwide distribution network. Its shares are considered a defensive holding due to stable demand for its products and a focus on operational discipline.
Colgate-Palmolive (COL) is a consumer products company with 33,600 employees, founded in 1806. The company ranks highly in categories like Quality of Pay and Work-Life Balance and offers a comprehensive benefits package including financial benefits (401k matching, tuition assistance), health benefits (medical, dental, vision, fertility, adoption, surrogacy assistance), and caregiver support. It also offers flexible work arrangements and paid internships, and has international offices.
Tom's of Maine, a Colgate-Palmolive brand, has agreed to pay $2.9 million to settle a lawsuit alleging that its "natural" toothpaste products were manufactured in a facility contaminated with mold and bacteria. Despite denying wrongdoing, the settlement addresses claims of deceptive practices following a federal inspection that found several types of bacteria in the water supply used for products and equipment. The company maintains that all finished goods are tested for safety and has implemented additional safeguards following the FDA's findings.
Swedbank AB has reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 5.2% in the first quarter, selling 217,139 shares, though it still holds a significant position valued at $337.8 million. Other institutional investors have adjusted their holdings, with many increasing their stakes. Colgate-Palmolive recently reported stronger-than-expected quarterly results, and analysts maintain a "Moderate Buy" consensus rating with an average price target of $95.88, alongside a declared quarterly dividend of $0.53 per share.
Colgate-Palmolive has streamlined its product content management by partnering with Syndigo and Flywheel, transitioning from fragmented data architectures to a centralized repository. This initiative has reduced content turnaround times from weeks to hours, improved data consistency across digital shelves, and boosted shopper engagement by 13%. The company now benefits from real-time syndication, automated governance, and enhanced SEO, ensuring a unified brand experience for consumers.
Colgate-Palmolive (ISIN US1941621039) operates in the mature consumer staples sector, focusing on oral, personal, and home care products with a diversified brand portfolio. The company's defensive positioning, strong global brands like Colgate toothpaste, and consistent demand for its essential products contribute to stable cash flows and make it an attractive option for investors seeking portfolio diversification. Pricing strategies, continuous innovation, and efficient operations are key to maintaining market leadership and shareholder returns through dividends.
DA Davidson has reiterated a Buy rating on WD-40 stock, expecting strong Q3 fiscal 2026 earnings with consistent double-digit sales growth. The firm anticipates the company will raise its profit guidance due to lower oil prices, which are more favorable than the current embedded outlook. Despite a recent earnings per share miss in Q2, WD-40's revenue exceeded forecasts, and the company announced leadership changes and a dividend payment.
Colgate-Palmolive (NYSE: CL), a Dividend King, has seen its stock rise 20.4% year-to-date in 2026, outperforming the S&P 500 and Nasdaq-100. The company's resilience stems from its strong global presence, diversified brand portfolio, and efficient operations, allowing it to navigate inflationary pressures effectively. Despite its premium valuation, Colgate-Palmolive offers a stable dividend and a balanced approach to capital allocation, making it an appealing investment for long-term growth and income.
Colgate-Palmolive (NYSE: CL), a Dividend King, has seen its stock rise 20.4% year-to-date in 2026, outperforming the S&P 500 and Nasdaq-100. The company's resilience stems from its global diversification, elite brand portfolio, and efficient operations, allowing it to navigate inflationary pressures and maintain strong margins. Despite its premium valuation, Colgate-Palmolive offers a stable, growing dividend and is considered a top buy for investors seeking a reliable dividend stock.
Colgate-Palmolive (NYSE: CL), a Dividend King, has seen its stock rise 20.4% year-to-date in 2026, outperforming the S&P 500 and Nasdaq-100. The company attributes this success to its strong brand portfolio, efficient operations, and significant international sales, which help mitigate U.S.-specific market pressures. Despite a premium valuation, its reliable dividend, supported by high free cash flow per share, and strategic reinvestment make it a compelling investment for stability and growth.
Colgate-Palmolive (India) Limited has significantly enhanced its supply chain resilience and sustainability, achieving 100% evaluated materials from audited partners and a 9% topline expansion. The company reached plastic positivity by collecting 101% of its plastic packaging volume, secured 23,312 International Renewable Energy Certificates, and implemented extensive social programs for oral health education, water conservation, and women's empowerment. These efforts are detailed in its latest BRSR report for the financial year 2025-26, highlighting a strong commitment to ethical guidelines and operational compliance.
Morningstar identified 10 new overvalued US-listed stocks this week, with Novartis, Lloyds Banking Group, and Colgate-Palmolive among those whose ratings changed to 2 stars. Additionally, Honeywell, Allstate, Guardant Health, and Nextpower moved into 1-star territory. These ratings indicate that the stock prices have climbed significantly above their fair value estimates, according to Morningstar's methodology.
Consumers who purchased Tom's of Maine toothpaste between November 21, 2020, and March 6, 2026, have until July 6, 2026, to file a claim in a class-action settlement. The lawsuit accused the company of deceptive practices, which the company denied but agreed to settle to avoid litigation. Claimants can submit forms online or via mail, with a final approval hearing for the settlement scheduled for September 10.
This page provides financial data for Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs (BCBA:CLD) on the Buenos Aires Stock Exchange, specifically focusing on its price to earnings forward ratio. The market was closed at the time of access, with no trades reported. The information is presented by TradingView, with data provided by ICE Data Services and FactSet.
Colgate-Palmolive has released its 2025 Sustainability & Social Impact Report, confirming it reached two billion children and families with oral health education since 1991. The company introduced new targets for 2030, aiming to reach 2.7 billion children and their families through its Colgate Bright Smiles, Bright Futures programme, and committed to net-zero carbon emissions by 2040. This strategy builds on its previous efforts, focusing on environmental protection, community investment, and advancements in product sustainability like recyclable toothpaste tubes and packaging.
/bmi/media/media_files/2026/07/06/colgate-palmolive-2026-07-06-09-48-22.jpg)
Colgate-Palmolive India is leveraging a "Many Indias" approach, artificial intelligence, and science-led innovation to enhance its products, communication, and retail execution, aiming for growth beyond mass toothpaste penetration. The company is investing significantly in advertising, focusing on moving oral care from a chore to a health cornerstone, and utilizing AI for everything from forecasting and customer development to artwork validation and content generation. Through strategies like premiumization, targeted campaigns with celebrities, and nationwide oral health initiatives, Colgate seeks to drive habit formation, increase frequency of use, and promote preventive oral care across diverse Indian demographics.
Freshpet (FRPT) was recently removed from several Russell growth indices and announced leadership changes, including co-founder Scott Morris's retirement and Nicola Baty's promotion to President. These developments, amidst increasing competition in the fresh pet food market, raise questions about the company's future growth trajectory and investor sentiment. The article suggests that while the core thesis for fresh pet food remains, these changes could influence liquidity and how institutional investors view the stock.
Colgate-Palmolive recently detailed its long-range 2030 plan, focusing on premium product offerings and enhanced digital-physical retail integration. This strategy aims to leverage the company's strong brands and consistent consumer demand to drive growth. While investors are watching closely for execution on these initiatives, the company's current high valuation leaves little room for underperformance if consumer caution or rising input costs impact margins.
Noel R. Wallace is the Chairman, President, and CEO of Colgate-Palmolive Company, a global consumer products company. His career at Colgate-Palmolive spans nearly four decades, beginning in 1987, and he has held various senior management roles across the world before becoming CEO in 2019 and Chairman in 2020. Wallace has emphasized digital and data transformation and has overseen the company's global expansion in its core categories.
Consumers who purchased Tom's of Maine toothpaste between November 21, 2020, and March 6, 2026, have until July 6, 2026, to file a claim in a $2.9 million class action settlement. The lawsuit accused the brand and Colgate-Palmolive of deceptive practices following a 2024 inspection that flagged issues like a "black mold-like substance" at a manufacturing facility. Claimants with proof of purchase can receive a full refund for up to three products, while those without proof may receive the average suggested retail price for one product.
A $2.9 million class action settlement involving Tom's of Maine toothpaste is nearing its claim deadline of July 6, 2026. The lawsuit accused the brand and its parent company, Colgate-Palmolive, of "deceptive and misleading business practices" following a 2024 inspection that flagged manufacturing issues like a "black mold-like substance." Consumers who purchased Tom's of Maine toothpaste between November 21, 2020, and March 6, 2026, are eligible to file a claim, with refunds potentially capped at three products per claimant, and payments contingent on the settlement receiving final approval in September 2026.
)
Colgate-Palmolive India plans to strengthen its leadership, enhance operational efficiency, and expand digital capabilities by 2030 to achieve sustainable growth and wider market reach. The company is using data analytics and AI to improve its value chain, reach more rural households, introduce science-led innovations in urban areas, and expand into adjacent categories. Despite challenges in FY26, the business stabilized in the second half, and the company expects accelerated momentum by focusing on category growth, cost discipline, and micro-distribution agility.
